Bank of Montreal’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bank of Montreal’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-25,000	Closed	-$2.61M	–	5000
2019 Q4	$2.61M	Hold	25,000	–	–	﹤0.01%	1728
2019 Q3	$2.88M	Hold	25,000	–	–	﹤0.01%	1454
2019 Q2	$4.31M	Hold	25,000	–	–	﹤0.01%	1280
2019 Q1	$4.21M	Sell	25,000 -25,000	-50%	-$3.72M	﹤0.01%	1256
2018 Q4	$4.87M	Sell	50,000 -5,000	-9%	-$656K	﹤0.01%	1085
2018 Q3	$9.5M	Buy	+55,000	New	+$7.93M	0.01%	914

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Bank of Montreal's GWPH Position: Q2 2021 in Review

Bank of Montreal sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1,460 shares — an estimated $318K sold.

Bank of Montreal first reported a position in GWPH in Q2 2013 and held it in 32 quarters. The position peaked at $10.5M in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Bank of Montreal reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Bank of Montreal sold 1,460 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $318K.
Bank of Montreal first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2013 and held it in 32 quarters.
Bank of Montreal's GW Pharmaceuticals Plc American Depositary Shares position peaked at $10.5M in Q2 2019.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.